Medlumics SL

Medlumics Logo

Medlumics is a Madrid-based MedTech company which develops Ablaview®, a unique RF irrigated ablation catheter system that merges photonics and miniaturized optics to guide device placement and directly assess the ablation lesions in real time.

Several of the investors of Medlumics were also backing Endosense, a company in the same space acquired by Abbott (St. Jude Medical) in 2013 for more than USD 300 million.

Learn more on